Randomized trial · people

Semaglutide: 16.0% weight loss at 68 weeks with therapy in STEP 3

Checked against the paper Randomized trialPublished by PepVault

The takeaway

Paired with intensive counseling and an early low-calorie diet, semaglutide roughly tripled the weight loss seen with counseling alone, with gut side effects as the main tradeoff.

Kind
Randomized trial
Studied in
People
Number studied
611
Published
2021
Journal
JAMA

What they tested

Does once-weekly semaglutide 2.4 mg add to the weight loss from intensive behavioral therapy and an early low-calorie diet in adults with overweight or obesity?

How the study was done

A randomized, double-blind, placebo-controlled phase 3a trial in 611 US adults without diabetes who had obesity, or overweight plus at least 1 related health problem. For 68 weeks, both groups got a low-calorie diet for the first 8 weeks and 30 counseling visits, plus either semaglutide or placebo (a dummy shot).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking semaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At week 68, body weight changed by -16.0% on semaglutide and -5.7% on placebo, a difference of -10.3 percentage points. A 5% or greater weight loss was reached by 86.6% on semaglutide vs 47.6% on placebo. Losses of at least 10% were reached by 75.3% vs 27.0%, and losses of at least 15% by 55.8% vs 13.2%. Stomach and gut side effects were more common on semaglutide (82.8% vs 63.2%), and 3.4% on semaglutide stopped treatment because of them, vs 0% on placebo.

What it doesn’t show

The trial ran 68 weeks, so it doesn't show whether the weight loss lasts, which the authors say needs more study. Most participants were women (81.0%), and people with diabetes were not included.

The paper

Wadden et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.

The compound

More studies on Semaglutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking semaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo